PHARMACEUTICALLY ACCEPTABLE SALTS OF PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND MEDICAL USE THEREOF
申请人:Jiangsu Hengrui Medicine Co., Ltd.
公开号:EP2532666A1
公开(公告)日:2012-12-12
Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof are disclosed. More specifically, pharmaceutically acceptable salts of (R,Z)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-methylene)-5-(2-hydroxy-3-morpholinyl-4-yl-propyl)-3-methyl-5,6,7,8-tetrahydro-1H-pyrrolo[3,2-c]azepin-4-one presented by formula (I), the preparation method and the use thereof as therapeutic agents, especially as protein kinase inhibitors, are disclosed.
本发明公开了吡咯氮杂环衍生物的药学上可接受的盐、其制备方法和医疗用途。更具体地说,本发明公开了式(I)所示的(R,Z)-2-(5-氟-2-氧代-1,2-二氢-吲哚-3-亚甲基)-5-(2-羟基-3-吗啉基-4-基-丙基)-3-甲基-5,6,7,8-四氢-1H-吡咯并[3,2-c]氮杂卓-4-酮的药学上可接受的盐、制备方法及其作为治疗剂,特别是作为蛋白激酶抑制剂的用途。